arrow
M

Miho Akabane

University System of Ohio
H指数:10
被引数:482

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Risk- adjusted Cumulative Sum (RA-CUSUM) method for real time monitoring of surgical units performance.

风险调整的累积和(RA-CUSUM)方法用于外科单元绩效的实时监测

HPB
IF2.4
2026-05-060
PRE
Genotype-Phenotype Associations Underlying Very Early Recurrence After Intrahepatic Cholangiocarcinoma Resection

肝内胆管癌切除术后极早期复发的基因型-表型关联

2026-05-010
PRE
BRAF Mutation Drives Early Multifocal Intrahepatic Recurrence after Curative Resection of Liver-Limited Colorectal Metastases

BRAF突变驱动肝局限性结直肠癌肝转移根治性切除后早期多灶性肝内复发

2026-03-260
PRE
Interplay of Tumor Morphology and Biology with Postoperative Complications: Prognostic Implications After Resection of Colorectal Liver Metastasis

肿瘤形态学与生物学特性与术后并发症的相互作用:结直肠癌肝转移切除后的预后意义

2026-02-180
OAAI
Prognostic Nutritional Index helps stratify outcomes of patients with intrahepatic cholangiocarcinoma undergoing curative-intent resection

预后营养指数有助于分层预测接受根治性切除的肝内胆管癌患者结局

2026-01-010
PRE
Advancing precision medicine in hepatocellular carcinoma: current challenges and future directions in liquid biopsy, immune microenvironment, single nucleotide polymorphisms, and conversion therapy

Akabane, M.; Imaoka, Y.; Kawashima, J.; Pawlik, T.M. 推进肝细胞癌的精准医学:液体活检、免疫微环境、单核苷酸多态性和转化治疗领域的当前挑战与未来方向。Hepatic Oncol. 2025, 12, 2493457. [Google Scholar] [CrossRef] [PubMed]

2025-12-318
PRE
Decoding risk factors for prolonged hospitalization after take-back to the operating room after liver transplantation: Escalating costs and clinical implications

解析肝移植术后返手术室再手术导致延长住院的风险因素:成本增加及临床意义

Surgery
IF2.7
2025-12-030
OAAI
Survival benefit of adjuvant chemotherapy for perihilar cholangiocarcinoma: Impact of log odds of metastatic lymph node count

辅助化疗对肝门部胆管癌的生存获益:转移淋巴结计数对数优势比的影响

Surgery
IF2.7
2025-12-010
PRE
Beyond the Composite: Differential Impact of Albumin and Bilirubin Relative to Tumor Burden in HCC

超越综合指标:白蛋白和胆红素相对于肝癌肿瘤负荷的差异化影响

2025-11-260
PRE